Market Cap 11.34M
Revenue (ttm) 3.00M
Net Income (ttm) 39.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,326.33%
Debt to Equity Ratio 0.00
Volume 447,400
Avg Vol 176,974
Day's Range N/A - N/A
Shares Out 16.79M
Stochastic %K 4%
Beta 1.13
Analysts Sell
Price Target $9.00

Latest News on PAVM

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 11:08 AM EDT - 14 days ago

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript


PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 3:49 PM EST - 5 months ago

PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript


PAVmed Inc. (PAVM) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 6:59 PM EDT - 8 months ago

PAVmed Inc. (PAVM) Q2 2024 Earnings Call Transcript


Lucid Diagnostics Launches New Corporate Website

Jul 11, 2024, 8:31 AM EDT - 9 months ago

Lucid Diagnostics Launches New Corporate Website

LUCD